News | October 16, 2025
IOL Chemicals receives EDQM certificate for Pantoprazole Sodium Sesquihydrate Process-III
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
Pantoprazole sodium is a proton pump inhibitor reduces stomach acid
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
IOL Chemicals and Pharmaceuticals has posted net profit of Rs.101.07 crores for the Financial Year ended March 31, 2025
Total Income during Q3 FY25 stood at Rs. 527.37 crore as compared to Rs. 528.77 crore in Q3 FY24
Total Income in Q2 FY25 stood at Rs. 532.18 crore
The company reported total income at Rs. 509.8 crore in Q1 FY25 as compared to Rs. 570.3 crore in Q1 FY24
EDQM has also issued a Certificate of Suitability for Allopurino
The company recently received CEP certificate approval for Losartan Potassium by EDQM
EBITDA for Q2 FY24 at Rs. 71.2 crore as compared to Rs. 79.9 crore QoQ
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
Subscribe To Our Newsletter & Stay Updated
